Trial Profile
The Vienna Prograf and Endothelial Progenitor Cell Extension Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacogenomic; Pharmacokinetics
- Acronyms PEP-X
- 30 Nov 2018 New trial record